Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global human growth hormone injection market size is calculated at USD 4.82 billion in 2026 and is expected to reach around USD 8.54 billion by 2035, ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...

HGH supplements for men are designed for bodybuilding and virility enhancing purposes that aid growth hormone production naturally. The method is not simple but it requires a lot of care and attention ...

Five years ago, Cass Almendral, a 56-year-old New Yorker who runs a consulting business, started injecting himself with synthetic human growth hormone (HGH) — and drastically changed his aging body.

(MENAFN- GlobeNewsWire - Nasdaq) The global human growth hormone injection market size is valued at USD 4.53 billion in 2025 and is predicted to hit around USD 8.54 billion by 2035, rising at a 6.55% ...